市場調査レポート

商品コード

PD-1とPD-L1阻害剤の世界市場、2024～2028年

Global PD-1 and PD-L1 Inhibitors Market 2024-2028

出版日: 2024年10月16日
発行: TechNavio
ページ情報: 英文 136 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 367,475円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 587,960円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

PD-1とPD-L1阻害剤市場、2024～2028年

PD-1とPD-L1阻害剤市場は2023～2028年に492億9,520万米ドル、予測期間中のCAGRは18.3％で成長すると予測されます。当レポートでは、PD-1とPD-L1阻害剤市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、がんの有病率の増加、患者支援プログラムの存在、PD-1とPD-L1阻害剤の高い標的親和性と特異性によって牽引されています。

市場範囲
基準年	2024年
終了年	2028年
予測期間	2024～2028年
成長モメンタム	加速
前年比[2024年]	15%
CAGR	18.3%
増分額	492億9,520万米ドル

本調査では、今後数年間のPD-1とPD-L1阻害剤市場成長を牽引する主要因の1つとして、強力なパイプラインを挙げています。また、PD-1とPD-L1阻害剤における戦略的提携や調査セグメントの拡大は、市場の大きな需要につながります。

地域別セグメンテーション
比較：地域別
北米：市場規模と予測 2023～2028年
欧州：市場規模と予測 2023～2028年
アジア：市場規模と予測 2023～2028年
その他：市場規模と予測 2023～2028年
米国：市場規模と予測 2023～2028年
ドイツ：市場規模と予測 2023～2028年
英国：市場規模と予測 2023～2028年
カナダ：市場規模と予測 2023～2028年
フランス：市場規模と予測 2023～2028年
地域情勢による市場機会

第9章促進要因・課題・機会・抑制要因

市場促進要因
市場課題
促進要因と課題の影響
市場機会・抑制要因

第10章競合情勢

概要
競合情勢
混乱の状況
産業のリスク

第11章競合分析

企業プロファイル
企業の市場ポジショニング
Agenus Inc.
Amgen Inc.
AnaptysBio Inc.
AstraZeneca Plc
BeiGene Ltd.
Bristol Myers Squibb Co.
Checkpoint Therapeutics Inc.
F. Hoffmann La Roche Ltd.
Merck and Co. Inc.
Pfizer Inc.

第12章付録

図表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global PD-1 And PD-L1 Inhibitors Market 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Application - Market share 2023-2028 (%)
Exhibits31: Data Table on Application - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Solid tumors - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Solid tumors - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Solid tumors - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Solid tumors - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Blood-related tumors - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Blood-related tumors - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Blood-related tumors - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Blood-related tumors - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Application ($ million)
Exhibits43: Data Table on Market opportunity by Application ($ million)
Exhibits44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits45: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits47: Chart on Geographic comparison
Exhibits48: Data Table on Geographic comparison
Exhibits49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits85: Market opportunity By Geographical Landscape ($ million)
Exhibits86: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2023 and 2028
Exhibits88: Overview on criticality of inputs and factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Companies covered
Exhibits92: Matrix on companies position and classification
Exhibits93: Agenus Inc. - Overview
Exhibits94: Agenus Inc. - Product / Service
Exhibits95: Agenus Inc. - Key offerings
Exhibits96: Amgen Inc. - Overview
Exhibits97: Amgen Inc. - Product / Service
Exhibits98: Amgen Inc. - Key offerings
Exhibits99: AnaptysBio Inc. - Overview
Exhibits100: AnaptysBio Inc. - Product / Service
Exhibits101: AnaptysBio Inc. - Key offerings
Exhibits102: AstraZeneca Plc - Overview
Exhibits103: AstraZeneca Plc - Product / Service
Exhibits104: AstraZeneca Plc - Key news
Exhibits105: AstraZeneca Plc - Key offerings
Exhibits106: BeiGene Ltd. - Overview
Exhibits107: BeiGene Ltd. - Business segments
Exhibits108: BeiGene Ltd. - Key offerings
Exhibits109: BeiGene Ltd. - Segment focus
Exhibits110: Bristol Myers Squibb Co. - Overview
Exhibits111: Bristol Myers Squibb Co. - Product / Service
Exhibits112: Bristol Myers Squibb Co. - Key news
Exhibits113: Bristol Myers Squibb Co. - Key offerings
Exhibits114: Checkpoint Therapeutics Inc. - Overview
Exhibits115: Checkpoint Therapeutics Inc. - Product / Service
Exhibits116: Checkpoint Therapeutics Inc. - Key offerings
Exhibits117: F. Hoffmann La Roche Ltd. - Overview
Exhibits118: F. Hoffmann La Roche Ltd. - Business segments
Exhibits119: F. Hoffmann La Roche Ltd. - Key news
Exhibits120: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits121: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits122: Merck and Co. Inc. - Overview
Exhibits123: Merck and Co. Inc. - Business segments
Exhibits124: Merck and Co. Inc. - Key news
Exhibits125: Merck and Co. Inc. - Key offerings
Exhibits126: Merck and Co. Inc. - Segment focus
Exhibits127: Pfizer Inc. - Overview
Exhibits128: Pfizer Inc. - Product / Service
Exhibits129: Pfizer Inc. - Key news
Exhibits130: Pfizer Inc. - Key offerings
Exhibits131: Inclusions checklist
Exhibits132: Exclusions checklist
Exhibits133: Currency conversion rates for US$
Exhibits134: Research methodology
Exhibits135: Information sources
Exhibits136: Data validation
Exhibits137: Validation techniques employed for market sizing
Exhibits138: Data synthesis
Exhibits139: 360 degree market analysis
Exhibits140: List of abbreviations

Product Code: IRTNTR74085

PD-1 And PD-L1 Inhibitors Market 2024-2028

The pd-1 and pd-l1 inhibitors market is forecasted to grow by USD 49295.2 mn during 2023-2028, accelerating at a CAGR of 18.3% during the forecast period. The report on the pd-1 and pd-l1 inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cancer, presence of patient assistance program, and high target affinity and specificity of pd-1 and pd-l1 inhibitors.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	15%
CAGR	18.3%
Incremental Value	$49295.2 mn

Technavio's pd-1 and pd-l1 inhibitors market is segmented as below:

By Application

Solid tumors
Blood-related tumors

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the strong pipeline as one of the prime reasons driving the pd-1 and pd-l1 inhibitors market growth during the next few years. Also, strategic alliances and expansion for research areas in pd-1 and pd-l1 inhibitors will lead to sizable demand in the market.

The report on the pd-1 and pd-l1 inhibitors market covers the following areas:

PD-1 And PD-L1 Inhibitors Market sizing
PD-1 And PD-L1 Inhibitors Market forecast
PD-1 And PD-L1 Inhibitors Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pd-1 and pd-l1 inhibitors market vendors that include Agenus Inc., Amgen Inc., AnaptysBio Inc., AstraZeneca Plc, BeiGene Ltd., Bristol Myers Squibb Co., Checkpoint Therapeutics Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Incyte Corp., MacroGenics Inc., Merck and Co. Inc., Merus N.V., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., and Sanofi SA. Also, the pd-1 and pd-l1 inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global PD-1 And PD-L1 Inhibitors Market 2018 - 2022
- Historic Market Size - Data Table on Global PD-1 And PD-L1 Inhibitors Market 2018 - 2022 ($ million)
4.2 Application segment analysis 2018 - 2022
- Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
- Chart on Application - Market share 2023-2028 (%)
- Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
6.3 Solid tumors - Market size and forecast 2023-2028
- Chart on Solid tumors - Market size and forecast 2023-2028 ($ million)
- Data Table on Solid tumors - Market size and forecast 2023-2028 ($ million)
- Chart on Solid tumors - Year-over-year growth 2023-2028 (%)
- Data Table on Solid tumors - Year-over-year growth 2023-2028 (%)
6.4 Blood-related tumors - Market size and forecast 2023-2028
- Chart on Blood-related tumors - Market size and forecast 2023-2028 ($ million)
- Data Table on Blood-related tumors - Market size and forecast 2023-2028 ($ million)
- Chart on Blood-related tumors - Year-over-year growth 2023-2028 (%)
- Data Table on Blood-related tumors - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

7 Customer Landscape

7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
8.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.11 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape

10.1 Overview
10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
- Overview on factors of disruption
10.4 Industry risks
- Impact of key risks on business

11 Competitive Analysis

11.1 Companies profiled
- Companies covered
11.2 Market positioning of companies
- Matrix on companies position and classification
11.3 Agenus Inc.
- Agenus Inc. - Overview
- Agenus Inc. - Product / Service
- Agenus Inc. - Key offerings
11.4 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key offerings
11.5 AnaptysBio Inc.
- AnaptysBio Inc. - Overview
- AnaptysBio Inc. - Product / Service
- AnaptysBio Inc. - Key offerings
11.6 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
11.7 BeiGene Ltd.
- BeiGene Ltd. - Overview
- BeiGene Ltd. - Business segments
- BeiGene Ltd. - Key offerings
- BeiGene Ltd. - Segment focus
11.8 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
11.9 Checkpoint Therapeutics Inc.
- Checkpoint Therapeutics Inc. - Overview
- Checkpoint Therapeutics Inc. - Product / Service
- Checkpoint Therapeutics Inc. - Key offerings
11.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
11.11 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
11.12 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings

12 Appendix

12.1 Scope of the report
12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
12.3 Currency conversion rates for US$
- Currency conversion rates for US$
12.4 Research methodology
- Research methodology
12.5 Data procurement
- Information sources
12.6 Data validation
- Data validation
12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
12.8 Data synthesis
- Data synthesis
12.9 360 degree market analysis
- 360 degree market analysis
12.10 List of abbreviations
- List of abbreviations

PD-1とPD-L1阻害剤の世界市場、2024～2028年

Global PD-1 and PD-L1 Inhibitors Market 2024-2028

目次

第1章エグゼクティブサマリー

第2章市場情勢

第3章市場規模

第4章市場規模実績

第5章ファイブフォース分析

第6章市場セグメンテーション：用途別

第7章顧客情勢

第8章地域別情勢

第9章促進要因・課題・機会・抑制要因

第10章競合情勢

第11章競合分析

第12章付録

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Application

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Opportunity/Restraints

10 Competitive Landscape

11 Competitive Analysis

12 Appendix

PD-1とPD-L1阻害剤の世界市場、2024～2028年

Global PD-1 and PD-L1 Inhibitors Market 2024-2028

目次

第1章 エグゼクティブサマリー

第2章 市場情勢

第3章 市場規模

第4章 市場規模実績

第5章 ファイブフォース分析

第6章 市場セグメンテーション：用途別

第7章 顧客情勢

第8章 地域別情勢

第9章 促進要因・課題・機会・抑制要因

第10章 競合情勢

第11章 競合分析

第12章 付録

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Application

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Opportunity/Restraints

10 Competitive Landscape

11 Competitive Analysis

12 Appendix

第1章エグゼクティブサマリー

第2章市場情勢

第3章市場規模

第4章市場規模実績

第5章ファイブフォース分析

第6章市場セグメンテーション：用途別

第7章顧客情勢

第8章地域別情勢

第9章促進要因・課題・機会・抑制要因

第10章競合情勢

第11章競合分析

第12章付録